ImmunoPhotonics

ImmunoPhotonics develops a proprietary carbohydrate polymer (GC) intended to be used in a therapeutic cancer vaccine. The company uses novel immunotherapy that begins with two injection procedure into accessible tumor and liberate and utilize the patient's tumor antigens to generate a systemic antitumor immune response, enabling healthcare providers to help in creating effective immunotherapies to eradicate cancer.